• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

How to Master a 30-Second Pitch That Gets You Noticed

May 3, 2026

Why Recruiters Are Scouting New Talent Outside the Office (and Where They’re Looking)

May 2, 2026

5 Things to Know About Trump’s New Retirement Plan — Including a $1,000 Government Match

May 1, 2026
Facebook Twitter Instagram
Trending
  • How to Master a 30-Second Pitch That Gets You Noticed
  • Why Recruiters Are Scouting New Talent Outside the Office (and Where They’re Looking)
  • 5 Things to Know About Trump’s New Retirement Plan — Including a $1,000 Government Match
  • 29 Summer Jobs for Teachers Who Want (or Need) to Earn Extra Money
  • Nearly half of Gen X workers are delaying retirement as rising costs, stagnant wages drain savings
  • How Homeownership Became America’s Most Misunderstood Investment
  • Most Americans Get These 3 Longevity Questions Wrong. Their Retirement Accounts Are Paying for It.
  • 10 Dollar-Store Items Seniors Buy to Save 30–50% Compared to Big-Box Retailers
Sunday, May 3
Facebook Twitter Instagram
FintechoPro
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
FintechoPro
Home » Ozempic and Other Weight-Loss Drugs Have Pummeled This Stock. It May Be a Buy.
Investing

Ozempic and Other Weight-Loss Drugs Have Pummeled This Stock. It May Be a Buy.

News RoomBy News RoomSeptember 27, 20235 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

RBC Capital Markets analyst Nik Modi gives Utz a $17 price target.


Dreamstime

Utz Brands
stock has taken a hit this year, but one analyst says now is the time to buy shares of the snack maker.

RBC Capital Markets analyst Nik Modi initiated coverage of
Utz
stock (ticker: UTZ) with an Outperform rating and a $17 price target, implying a 25% increase to the stock’s Monday closing price. This bullish initiation comes after shares of the maker of potato chips, cheeseballs, pretzels, and more salty treats have dropped 13% this year.

One reason for Wall Street’s concern is the recent popularity of weight-loss drugs like Mounjaro, Ozempic, and Wegovy, and what that could mean for the snack food industry.
Novo Nordisk’s
(NVO) Ozempic and
Eli Lilly’s
(LLY) Mounjaro are two diabetes drugs being used by some for weight management. while Novo’s Wegovy has been approved for weight loss.

Modi wrote in a research note Tuesday that some investors are concerned by what the growing popularity of these drugs could mean for the stock, especially since they cause users to have a smaller appetite and require the people taking them to eat healthy foods to see results.

“We are not in this camp,” Modi said. “We must not forget that these drugs are expensive and out of reach for many Americans seeking to use them for weight loss as a result.”

“Consumption of indulgent salty snacks that would be considered ‘junk food’ generally over-indexes toward lower-income individuals, who are unlikely to be these drugs’ primary users,” the analyst added.

Modi also recognized that there are other concerns within the snack space as consumers continue to feel the pinch of high grocery prices as inflation runs hot. With prices historically high, shoppers may choose to trade down to store brands or avoid buying snacks altogether.

The analyst says these pressures will continue in the near term, but the stock is compelling for investors willing to wait.

“
Utz
is a pure-play salty snack company—which is one of the most attractive segments of the consumer-staples industry due to its faster growth, low exposure to private label and structural long-term drivers such as growth in smaller households and snacking extending to more occasions,” Modi said. “In addition, we believe Utz has significant opportunity to extend its geographic reach as its current sales base is concentrated in Northeast and Mid-Atlantic.”

Utz stock is rising 1.7% Tuesday to $13.80.

Write to Angela Palumbo at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Even Time-Strapped Business Owners Can Share an Engaging Reading Experience with Their Kids

Investing September 20, 2025

Turnover Is Costing You More Than You Think — Here’s the Fix

Investing September 19, 2025

How Pana Food Truck Started Selling Arepas

Investing September 18, 2025

Amazon CEO Andy Jassy Is Fighting Against Bureaucracy

Investing September 17, 2025

Here Are the Top 50 Mistakes I’ve Seen Kill New Companies

Investing September 16, 2025

Google Parent Alphabet Reaches $3T Market Cap

Investing September 15, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Why Recruiters Are Scouting New Talent Outside the Office (and Where They’re Looking)

May 2, 20262 Views

5 Things to Know About Trump’s New Retirement Plan — Including a $1,000 Government Match

May 1, 20261 Views

29 Summer Jobs for Teachers Who Want (or Need) to Earn Extra Money

April 30, 20263 Views

Nearly half of Gen X workers are delaying retirement as rising costs, stagnant wages drain savings

April 30, 20262 Views
Don't Miss

How Homeownership Became America’s Most Misunderstood Investment

By News RoomApril 29, 2026

A mortgage is a government-subsidized forced savings plan — not the wealth machine Wall Street…

Most Americans Get These 3 Longevity Questions Wrong. Their Retirement Accounts Are Paying for It.

April 29, 2026

10 Dollar-Store Items Seniors Buy to Save 30–50% Compared to Big-Box Retailers

April 29, 2026

How To Interpret And Use Medicare’s Nursing Home Ratings

April 28, 2026
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2026 FintechoPro. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.